Compare Gilead Sciences, Inc. (GILD) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Utilities Select Sector SPDR Fund — how do they compare? Gilead Sciences, Inc. trades at $151.17 (market cap $182.40B), while Utilities Select Sector SPDR Fund trades at $41.39 (market cap $23.60B). The key difference: Gilead Sciences, Inc. is far larger — about 7.7× Utilities Select Sector SPDR Fund's market cap, and Gilead Sciences, Inc. pays a 2.23% dividend while Utilities Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gilead Sciences, Inc. for 111 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| GILD | XLU | |
|---|---|---|
Market Cap | $182.40B | $23.60B |
Volume | 4,469,821 | 28,758,237 |
Sector | Health | — |
52-Week High | $155.80 | $47.73 |
52-Week Low | $116.74 | $39.25 |
Typical Hold Time | 111 Days | 80 Days |
Enterprise Value | $205.46B | — |
Dividend Yield | 2.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $151.17, up 2.94% recently, with strong technical momentum and bullish moving averages. The company shows robust revenue growth to $29.44B in 2025 and beat earnings estimates in three consecutive quarters, though net income margin turned negative at -10.64% for 2026. Recent developments include expanded HIV drug access in Latin America via a PAHO partnership, positioning Gilead for growth in its core franchises.
Gilead presents a mixed outlook with solid operational cash flow and analyst bullishness (65.5% buy ratings) offset by profitability concerns and high debt levels. The stock's current price aligns with the consensus target of $151.57, suggesting limited near-term upside. Key risks include execution in oncology pipeline expansion and reliance on HIV treatment revenues amid competitive pressures.
XLU trades at $41.39, up 0.58% today, with technical indicators showing a mixed but overall bullish signal. The ETF recently hit 52-week lows around $39.13 amid sector-wide pressure from rising interest rates. Moving averages suggest bullish momentum, while oscillators remain neutral with RSI at 54.66 indicating balanced momentum. Recent news highlights utility stocks as oversold, creating potential buying opportunities for defensive investors.
The outlook remains cautious due to interest rate sensitivity, but current levels may offer value for long-term investors seeking defensive exposure. Key risks include further rate hikes and regulatory challenges, while potential catalysts include AI-driven power demand and defensive positioning during market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
